Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay

Journal of Investigative Dermatology

Volumn 109, Issue 1, 1997, Pages 69-73

  Kemp, E Helen ^a   Gawkrodger, David J ^b   MacNeil, Sheila ^a   Watson, Philip F ^a   Weetman, Anthony P ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity

Indexed keywords

AUTOANTIBODY; MONOPHENOL MONOOXYGENASE; RECOMBINANT ENZYME;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VITILIGO;

EID: 0030786941     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12276556     Document Type: Article

References (12)

1. Baharav E, Merimski O, Shoenfeld Y, Zigelman R, Gilbrund B, Yecheskel G: Tyrosinase as an autoantigen in patients with vitiligo. Clin Exp Immunol 105:84-88, 1996
2. Cui J, Harning R, Henn M, Bystryn JC: Identification of pigment cell antigens defined by vitiligo antibodies. J Invest Dermatol 98:162-165, 1992
3. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark A: Radioimmunoassay detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 19:113-125, 1994
4. Falorni A, Nikoshokov A, Laureti S, Grenback E, Hulting A-L, Casucci G, Santeusanio F, Brunetti P, Luthman H, Lernmark: High diagnostic accuracy tor idiopathic Addison's disease with a sensitive radiobinding assay tor autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 80:2752-2755, 1995
5. Harning R, Cui J, Bystryn JC: Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol 97:1078-1080, 1991
6. Naughton GK, Reggiardo D, Bystryn JC: Correlation between vitiligo antibodies and extent of depigmentation in vitiligo. J Am Acad Dermatol 15:978-981, 1986
7. Norris DA, Kissinger RM, Naughton GK, Bystryn JC: Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocytes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity (ADDC). J Invest Dermatol 90:783-789, 1988
8. Peterson P, Perheentupa J, Krohn KJE: Detection ot candidal antigens in autoimmune polyglandular syndrome type I. Clin Diagn Lab Immunol 3:290-294, 1996
9. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989
10. Song YH, Connor E, Li Y, Zorovich B, Balducci P, Maclaren N: The role of tyrosinase in autoimmune vitiligo. Lancet 344:1049-1052, 1994
11. Takeda A, Tomita Y, Okinaga S, Tagami H, Shibahara S: Functional analysis of the cDNA encoding human tyrosinase precursor. Biochem Biophys Res Commun 162:984-990, 1989
12. Tsukamoto K, Jackson IJ, Urabe K, Montague PM, Hearing VJ: A second tyrosinase-related protein, TRP2, is a melanogenic enzyme termed DOPAchrome tautomerase. EMBO J 11:519-526, 1992